Role of P-glycoprotein in absorption of novel antimalarial drugs

QR Code

Role of P-glycoprotein in absorption of novel antimalarial drugs

Bibliographic Details
Main Authors:	Crowe, Andrew, Ilett, K., Karunajeewa, H., Batty, Kevin, Davis, Timothy
Format:	Journal Article
Published:	American Society for Microbiology 2006
Online Access:	http://hdl.handle.net/20.500.11937/16739

Similar Items

The interactions of P-glycoprotein with antimalarial drugs, including substrate affinity, inhibition and regulation
by: Senarathna, S., et al.
Published: (2016)

The role of p-glycoprotein in bacterial attachment to intestinal cells.
by: Crowe, Andrew
Published: (2010)

Limited P-glycoprotein mediated efflux for anti-epileptic drugs.
by: Crowe, Andrew, et al.
Published: (2006)

Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin
by: Gibbons, Peter, et al.
Published: (2007)

Synthesis and antimalarial evaluation of novel isocryptolepine derivatives
by: Whittell, Louise, et al.
Published: (2011)

The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers
by: Crowe, Andrew, et al.
Published: (2011)

Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing
by: Senarathna, Senarathna Mudiyanselage Dona, et al.
Published: (2014)

The role of P-glycoprotein and breast cancer resistance protein (BCRP) in bacterial attachment to human gastrointestinal cells
by: Crowe, Andrew
Published: (2011)

Inhibition of P-glycoprotein - Mediated Efflux of Digoxinand Its Metabolites by Macrolide Antibiotics
by: Hughes, Jeffery, et al.
Published: (2010)

Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
by: Crowe, Andrew, et al.
Published: (2012)

Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling
by: Salman, S., et al.
Published: (2017)

Expressions of P-glycoprotein in treatment: Resistant Helicobacter pylori patients
by: Omar, Marhanis, et al.
Published: (2014)

Interrelationship between Heliobacter pylori and P-glycoprotein: potential role in drug resistance and carcinogenicity
by: Omar, Marhanis Salihah
Published: (2013)

Optimal antimalarial dose regimens for sulfadoxine-pyrimethamine with or without azithromycin in pregnancy based on population pharmacokinetic modeling
by: Salman, S., et al.
Published: (2017)

Clinical Pharmacology Of Antimalarial Drugs.
Published: (1989)

ABCB1 (P-glycoprotein) reduces bacterial attachment to human gastointestinal LS174T epithelial cells
by: Crowe, Andrew, et al.
Published: (2012)

Pharmacokinetics and allometric scaling of antimalarial drugs
by: Senarathna, Senarathna Mudiyanselage Dona Kalyani Ganga
Published: (2015)

The antimalarial drug quinine interferes with serotonin biosynthesis and action
by: Islahudin, Farida, et al.
Published: (2014)

Location of contact residues in pharmacologically distinct drug binding sites on P-glycoprotein
by: Mittra, Rituparna, et al.
Published: (2017)

Pharmacokinetics of dihydroartemisinin in a murine malaria model
by: Batty, Kevin, et al.
Published: (2008)

P-glycoprotein expression in Helicobacter pylori-positive patients: The influence of MDR1 C3435T polymorphism
by: Omar, Marhanis, et al.
Published: (2012)

Heterologous expression of a novel drug transporter from the malaria parasite alters resistance to quinoline antimalarials
by: Tindall, Sarah M., et al.
Published: (2018)

A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
by: Karunajeewa, H., et al.
Published: (2008)

Determination Of Mitragynine As A Substrate, Inducer, Or Inhibitor Of P-Glycoprotein Drug Transporter, And Prediction Of Drug-Herb Interaction Risks
by: Rusli, Noradliyanti
Published: (2017)

Molecular Cloning, Expression, And Characterization Of Glutathione-Stransferase As A Novel Target In Antimalarial Drug Design And Discovery
by: Al-Qattan, Mohammed Nooraldeen Mahmod
Published: (2015)

Modelling the time course of antimalarial parasite killing: A tour of animal and human models, translation and challenges
by: Patel, K., et al.
Published: (2015)

The candidate antimalarial drug MMV665909 causes oxygen-dependent mRNA mistranslation and synergises with quinoline-derived antimalarials
by: Vallieres, Cindy, et al.
Published: (2017)

Pharmacodynamic studies of antimalarial drugs in a murine malaria model
by: Moore, Brioni R.
Published: (2011)

Application of yeast to understanding the mode of action of the antimalarial drug artesunate
by: Wilson, Jonathan M.
Published: (2014)

Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine
by: Islahudin, Farida, et al.
Published: (2013)

Effect of some antimalarial drugs on the liver: biochemical and histopathological studies
by: Al-Ani, Imad Matloub Dally, et al.
Published: (2013)

Toxicology and pharmacokinetics of piperaquine in mice
by: Batty, Kevin, et al.
Published: (2008)

Quality of antimalarial drugs and antibiotics in Papua New Guinea: A survey of the health facility supply chain
by: Hetzel, M., et al.
Published: (2014)

Discovery of antimalarial drugs from streptomycetes metabolites using a metabolomic approach
by: Ahmad, Siti Junaidah, et al.
Published: (2017)

The antimalarial drug primaquine targets Fe–S cluster proteins and yeast respiratory growth
by: Lalève, Anaïs, et al.
Published: (2016)

Identification of natural peptides as a new class of antimalarial drugs by in silico approaches
by: Samy, R., et al.
Published: (2017)

Artemisinin and its derivatives
by: Ilett, Kenneth, et al.
Published: (2005)

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria
by: Karunajeewa, H., et al.
Published: (2008)

The influence of passage number for Caco2 cell models when evaluating P-gp mediated drug transport
by: Senarathna, Ganga, et al.
Published: (2015)

Effect of oils on drug absorption
by: Palin, K.J.
Published: (1981)